CareSet gets accelerated access to Medicare data to perform COVID data analysis
CareSet is proud to announce that we are now the FIRST (that we know of) company with access to fee-for-service claims data (Part A, B & D), refreshed monthly, and with an industry best 2-week lag.
CareSet is using this data to perform analysis of the ongoing COVID pandemic, and how it impacts Medicare patients across the country. This data is the basis for our recent collaboration with the Wall Street Journal on how COVID has impacted Skilled Nursing Facilities across the country. The data also supports our structural analysis on the US hospital system, in conjunction with our work with HHS on the COVID Hospital Data Public Use File.
CareSet “firsts” are a result of a unique, historic, and ongoing collaboration with CMS and HHS and our expertise in data analytics and our commitment to data transparency. Our unique access provides CareSet with over 12 years of data and experience with the “biggest payor” in the US– supporting many of the top 20 pharma and biotech manufacturers.
For more information, please also see our most recent at-a-glance summary.
Analytics, Marketing, and Market Access teams can learn more about monthly refreshed Part D data and it’s ability to help gain insight into the impact of the COVID Pandemic, by contacting Brian Lang, VP of Marketing, CareSet, at firstname.lastname@example.org
Redaction: Previous versions of this blog post stated that we are the “First and Only” company to get this data access, which is not accurate. We believe CareSet was the first commercial/Innovator VRDC seat holder to get access to this data, but there are other VRDC seat holders who have received recent claims data as a result of COVID. We know that non-commercial users were granted access to this data prior to CareSet’s access. Also, previous versions of this article could be construed to mean that CareSet has an exclusive partnership with CMS, which is not true. We pride ourselves in being the first in the queue for CMS data access, and in advocating (and even suing in support of the public’s FOIA rights) for greater public access to CMS data. As a result of these efforts we have a track record of receiving access to data before other organizations.